Nasdaq · Biotech stocks database

ISPC — iSpecimen Inc.

ISPC (iSpecimen Inc.) stock: $1.33, $3.3M market cap, $9.0M cash, -$5.7M EV, $3.9M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$1.33

Market cap

$3.3M

Cash

$9.0M

Enterprise value

-$5.7M

Balance sheet

Cash	$9.0M
Debt	$0.0M
Net cash	$9.0M
Enterprise value	-$5.7M
Basic shares	1.5M shares
Fully diluted shares	2.9M shares
Fully diluted market cap	$3.9M
Cash per share	$5.97

Cash figures as of 2026-08-07. Database snapshot: 2026-09-21.

Price history

Loading ISPC daily closes…

Loading price history…

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT03848962	Not disclosed	Recruiting	Sponsor	ISPC	—	Cancer; Healthy; Gastrointestinal Complication	—

Sponsor-matched active trials from ClinicalTrials.gov (1 as sponsor, 0 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for iSpecimen Inc on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego